Initial Real-World Practical Experience of Sacubitril/Valsartan Treatment in Japanese Patients With Chronic Heart Failure

Background: Sacubitril/valsartan, an angiotensin receptor-neprilysin inhibitor, has demonstrated survival benefit and reduces heart failure hospitalization compared with enalapril in patients with heart failure and reduced ejection fraction. However, its efficacy in real-world practice in Japan rema...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Makiko, Imamura, Teruhiko, Joho, Shuji, Kinugawa, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Circulation Society 2021
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492400/
https://www.ncbi.nlm.nih.gov/pubmed/34703936
http://dx.doi.org/10.1253/circrep.CR-21-0068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492400/
https://www.ncbi.nlm.nih.gov/pubmed/34703936
http://dx.doi.org/10.1253/circrep.CR-21-0068

Ejemplares similares